市場調査レポート

商品コード

1206506

中東・アフリカのマラリア治療薬市場の2028年までの予測-地域別分析-治療薬、薬剤タイプ、投与経路、流通チャネル、エンドユーザー別

Middle East & Africa Malaria Treatment Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Treatment, Drug Type, Route of Administration, Distribution Channel, and End User

出版日: 2023年01月24日 | 発行: The Insight Partners

| ページ情報: 英文 229 Pages | 納期: 即納可能

価格

PDF (Single User License)

USD 3,000 471,420円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は一度のみ可能です。印刷したもののご利用はPDFのライセンス保持者に限定されます。

PDF (Site License)

USD 4,000 628,560円

レポートPDFを同一事業所（所在地）内のすべての方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 5,000 785,700円

レポートPDFを企業内すべての方に使用頂けるライセンスです。PDF内のテキスト等のコピーは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=157.14円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

中東・アフリカのマラリア治療市場は、2022年の5,135万米ドルから2028年には6,302万米ドルに成長すると予測されています。2022年から2028年までのCAGRは3.5%で成長すると推定されています。

マラリアの有病率の増加が中東・アフリカのマラリア治療市場に拍車をかける

世界保健機関（WHO）によると、マラリアは、感染した雌のアノフェレス蚊に刺されることで広がる原虫寄生による急性熱性疾患です。マラリアは、ヒトに寄生する5種類の寄生虫によって引き起こされますが、そのうちの2種類（Plasmodium falciparumとP. vivax）が最大の脅威となっています。マラリア原虫は、最も致命的な寄生虫であり、アフリカ大陸で最も蔓延している寄生虫です。WHOのアフリカ地域は、マラリアの世界の負担のうち、不釣り合いに高い割合を占め続けています。2020年には、世界のマラリア患者の95％、死亡者の96％がアフリカで報告され、マラリアによる死亡者全体の～80％が5歳以下の子供で報告されています。アフリカの4カ国-ナイジェリア（31.9%）、コンゴ民主共和国（13.2%）、タンザニア連合共和国（4.1%）、モザンビーク（3.8%）は、世界中で報告されているマラリア関連死亡の約半分を占めています。また、「LANCET Regional Health 2020」によると、マラリアによる死亡率はアフリカ諸国が最も高く（95％）、5歳未満の子どもの死亡率の大部分（～77％）はP. falciparumであり、アフリカ諸国では、マラリアによる子どもの死亡率全体の～96％をこの種が占めています。マラリアの有病率の上昇は、中東・アフリカのマラリア治療市場の成長を後押ししています。

中東・アフリカのマラリア治療市場の概要

中東・アフリカのマラリア治療市場は、UAE、サウジアラビア、南アフリカ、ナイジェリア、コンゴ民主共和国、タンザニア連合共和国、モザンビーク、ウガンダ、ガーナ、ブルキノファソ、ケニア、ザンビア、およびその他の中東・アフリカに分類されます。2021年、サウジアラビアはこの地域のマラリア治療薬の最大市場でした。2020年、サウジアラビアでは3,367人のマラリア感染者が示されました。さらに、15歳以上の10代で3,304人のマラリア感染者（98％）が記録されました。サウジアラビアにおける現在の撲滅・治療戦略は、主に高リスク地域を対象とし、迅速な確定診断と治療による感染管理などの持続的な予防策に重点を置いています。適切な治療とベクターコントロールによる個々の症例のフォローアップと反応性サーベイランス、スクリーニングと治療による国境での積極的な症例検出。また、現在のマラリア治療は、アルテミシニンベースの組み合わせの使用が基本となっています。サウジアラビアでは、ピリメタミン／スルファドキシン／アルテスネートの組み合わせが、合併症のないマラリアの治療の第一選択であり、ルメファントリン／アルテメザー（Coartem）は第二選択として使用されています。重症マラリアの治療は、キニーネまたはアルテスネートの使用にかかっています。

中東・アフリカのマラリア治療市場の収益と2028年までの予測（US$Million）

中東・アフリカのマラリア治療市場の細分化

中東・アフリカのマラリア治療市場は、治療、薬剤タイプ、投与経路、流通チャネル、エンドユーザー、国に基づいてセグメント化されています。

治療法に基づき、中東・アフリカのマラリア治療市場は、処方薬、ワクチン、診断テスト、その他に区分されます。2022年には、診断テストセグメントが最大の市場シェアを占めています。処方薬セグメントはさらに、リン酸クロロキン、アルテミシニンベースの併用療法（ACT）、アトバキン・プログアニル、ドキシサイクリン入り硫酸キニーネ（クアラキン）、リン酸プリマキン、その他に分類されます。

薬剤の種類に基づき、中東・アフリカのマラリア治療市場はブランド品とジェネリック品に二分されます。2022年の市場シェアはジェネリックセグメントが大きくなっています。

投与経路に基づき、中東・アフリカのマラリア治療市場は経口と非経口・静脈に二分されます。2022年には経口剤がより大きな市場シェアを占めています。

流通チャネルに基づき、中東・アフリカのマラリア治療市場は、直接入札、病院薬局、小売薬局、オンライン薬局、その他に区分されます。2022年には、直接入札セグメントが最も大きな市場シェアを占めています。

エンドユーザーに基づき、中東・アフリカのマラリア治療市場は、病院、専門クリニック、在宅ケア、その他に区分されます。専門クリニックセグメントが2022年に最大の市場シェアを占めました。

国別に見ると、中東・アフリカのマラリア治療市場は、サウジアラビア、南アフリカ、UAE、ナイジェリア、コンゴ民主共和国、タンザニア連合共和国、モザンビーク、ウガンダ、ガーナ、ブルキナファソ、ケニア、ザンビア、その他中東・アフリカに分類されています。地域別分析では、2022年にサウジアラビアが市場を独占しているとされています。

AdvaCare Pharma USA LLC、Cipla Ltd、GSK Plc、Lupin Ltd、Novartis AG、Sanofi SA、Sun Pharmaceutical Industries Ltd、Viatris Inc、Zydus Healthcare Ltdは、中東・アフリカのマラリア治療市場で活動している主要企業の1つです。

市場促進要因
- マラリアの有病率の増加
- マラリアに対する意識を高めるための政府および民間セクターの取り組み
市場抑制要因
- 抗マラリア薬の偽造とその後の薬剤耐性化
市場機会
- 新薬とワクチンのパイプラインの拡大
今後の動向
- 迅速な診断テスト
影響度分析

第6章マラリア治療市場-中東・アフリカの分析

中東・アフリカのマラリア治療市場の収益予測と分析

第7章中東・アフリカのマラリア治療市場分析：治療別

中東・アフリカのマラリア治療市場：治療別2021年・2028年（%）
処方薬
ワクチン
診断用検査
その他

第8章中東・アフリカのマラリア治療市場の分析：薬剤タイプ別

中東・アフリカのマラリア治療市場：薬剤タイプ別2021年・2028年（%）
ブランド品
ジェネリック医薬品

第9章中東・アフリカのマラリア治療市場の分析：投与経路別

中東・アフリカのマラリア治療市場：投与経路別2021年・2028年（%）
経口投与
非経口および静脈内投与モード

第10章中東・アフリカのマラリア治療市場の分析：流通チャネル別

中東・アフリカのマラリア治療市場：流通チャネル別2021年・2028年（%）
直接入札
病院薬局
小売薬局
オンライン薬局
その他

第11章中東・アフリカのマラリア治療薬の市場分析：エンドユーザー別

中東・アフリカのマラリア治療市場：エンドユーザー別2021年・2028年（%）
病院
専門クリニック
ホームケア
その他

第12章中東・アフリカのマラリア治療市場：国別分析

中東・アフリカ
- UAE（アラブ首長国連邦）
- サウジアラビア
- 南アフリカ
- ナイジェリア
- コンゴ民主共和国
- タンザニア連合共和国
- モザンビーク
- ウガンダ
- ガーナ
- ブルキナファソ
- ケニア
- ザンビア
- その他の中東・アフリカ

第13章業界情勢

無機的成長戦略
有機的な成長戦略

第14章企業プロファイル

Zydus Healthcare Ltd
Sun Pharmaceutical Industries Ltd
Sanofi SA
GSK Plc
Novartis AG
Cipla Ltd
Viatris Inc
Lupin Ltd
AdvaCare Pharma USA LLC

第15章付録

図表

List Of Tables

Table 1. MEA Malaria Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Table 2. UAE: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)
Table 3. UAE: Malaria Treatment Market, by Prescription Medication - Revenue and Forecast to 2028 (US$ Million)
Table 4. UAE: Malaria Treatment Market Revenue and Forecasts to 2028, By Drug Type (US$ Million)
Table 5. UAE: Malaria Treatment Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 6. UAE: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
Table 7. UAE: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 8. Saudi Arabia: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)
Table 9. Saudi Arabia: Malaria Treatment Market, by Prescription Medication - Revenue and Forecast to 2028 (US$ Million)
Table 10. Saudi Arabia: Malaria Treatment Market Revenue and Forecasts to 2028, By Drug Type (US$ Million)
Table 11. Saudi Arabia: Malaria Treatment Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 12. Saudi Arabia: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
Table 13. Saudi Arabia: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 14. South Africa Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)
Table 15. South Africa: Malaria Treatment Market, by Prescription Medication - Revenue and Forecast to 2028 (US$ Million)
Table 16. South Africa: Metabolomics Market Revenue and Forecasts to 2028, By Drug Type (US$ Million)
Table 17. South Africa: Metabolomics Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 18. South Africa: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
Table 19. South Africa: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 20. Nigeria Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)
Table 21. Nigeria: Malaria Treatment Market, by Prescription Medication - Revenue and Forecast to 2028 (US$ Million)
Table 22. Nigeria: Malaria Treatment Market Revenue and Forecasts to 2028, By Drug Type (US$ Million)
Table 23. Nigeria: Malaria Treatment Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 24. Nigeria: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
Table 25. Nigeria: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 26. The Democratic Republic of Congo Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)
Table 27. The Democratic Republic of Congo: Malaria Treatment Market, by Prescription Medication - Revenue and Forecast to 2028 (US$ Million)
Table 28. The Democratic Republic of Congo: Malaria Treatment Market Revenue and Forecasts to 2028, By Drug Type (US$ Million)
Table 29. The Democratic Republic of Congo: Malaria Treatment Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 30. The Democratic Republic of Congo: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
Table 31. The Democratic Republic of Congo: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 32. United Republic of Tanzania Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)
Table 33. United Republic of Tanzania: Malaria Treatment Market, by Prescription Medication - Revenue and Forecast to 2028 (US$ Million)
Table 34. United Republic of Tanzania: Malaria Treatment Market Revenue and Forecasts to 2028, By Drug Type (US$ Million)
Table 35. United Republic of Tanzania: Malaria Treatment Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 36. United Republic of Tanzania: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
Table 37. United Republic of Tanzania: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 38. Mozambique Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)
Table 39. Mozambique: Malaria Treatment Market, by Prescription Medication - Revenue and Forecast to 2028 (US$ Million)
Table 40. Mozambique: Metabolomics Market Revenue and Forecasts to 2028, By Drug Type (US$ Million)
Table 41. Mozambique Metabolomics Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 42. Mozambique: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
Table 43. Mozambique: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 44. Uganda: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)
Table 45. Uganda: Malaria Treatment Market, by Prescription Medication - Revenue and Forecast to 2028 (US$ Million)
Table 46. Uganda: Malaria Treatment Market Revenue and Forecasts to 2028, By Drug Type (US$ Million)
Table 47. Uganda: Malaria Treatment Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 48. Uganda: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
Table 49. Uganda: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 50. Ghana: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)
Table 51. Ghana: Malaria Treatment Market, by Prescription Medication - Revenue and Forecast to 2028 (US$ Million)
Table 52. Ghana: Metabolomics Market Revenue and Forecasts to 2028, By Drug Type (US$ Million)
Table 53. Ghana: Metabolomics Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 54. Ghana: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
Table 55. Ghana: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 56. Burkina Faso: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)
Table 57. Burkina Faso: Malaria Treatment Market, by Prescription Medication - Revenue and Forecast to 2028 (US$ Million)
Table 58. Burkina Faso: Malaria Treatment Market Revenue and Forecasts to 2028, By Drug Type (US$ Million)
Table 59. Burkina Faso: Malaria Treatment Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 60. Burkina Faso: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
Table 61. Burkina Faso: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 62. Kenya: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)
Table 63. Kenya: Malaria Treatment Market, by Prescription Medication - Revenue and Forecast to 2028 (US$ Million)
Table 64. Kenya: Malaria Treatment Market Revenue and Forecasts to 2028, By Drug Type (US$ Million)
Table 65. Kenya: Malaria Treatment Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 66. Kenya: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
Table 67. Kenya: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 68. Zambia: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)
Table 69. Zambia: Malaria Treatment Market, by Prescription Medication - Revenue and Forecast to 2028 (US$ Million)
Table 70. Zambia: Metabolomics Market Revenue and Forecasts to 2028, By Drug Type (US$ Million)
Table 71. Zambia: Metabolomics Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 72. Zambia: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
Table 73. Zambia: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 74. Rest of MEA: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)
Table 75. Rest of MEA: Malaria Treatment Market, by Prescription Medication - Revenue and Forecast to 2028 (US$ Million)
Table 76. Rest of MEA: Metabolomics Market Revenue and Forecasts to 2028, By Drug Type (US$ Million)
Table 77. Rest of MEA: Metabolomics Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 78. Rest of MEA: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
Table 79. Rest of MEA: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 80. Recent Inorganic Growth Strategies
Table 81. Recent Organic Growth Strategies in the Malaria Treatment Market
Table 82. Glossary of Terms Glossary of Terms

List Of Figures

Figure 1. MEA Malaria Treatment Market Segmentation
Figure 2. MEA Malaria Treatment Market Segmentation, By Country
Figure 3. MEA Malaria Treatment Market Overview
Figure 4. MEA Malaria Treatment Market, By Distribution Channel
Figure 5. MEA Malaria Treatment Market, By Country
Figure 6. MEA PEST Analysis
Figure 7. MEA Malaria Treatment Market impact analysis of driver and restraints
Figure 8. MEA Malaria Treatment Market - Revenue Forecast and Analysis
Figure 9. MEA Malaria Treatment Market, by Treatment 2021 & 2028 (%)
Figure 10. Prescription Medication: MEA Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 11. Chloroquine Phosphate: MEA Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 12. Artemisinin- based Combination Therapies (ACTs): MEA Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 13. Atovaquone-Proguanil: MEA Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 14. Quinine Sulphate (Qualaquin) with Doxycycline: MEA Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 15. Primaquine Phosphate: MEA Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 16. Others: MEA Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 17. Vaccines: MEA Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 18. Diagnostic Tests: MEA Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 19. Others: MEA Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 20. MEA Malaria Treatment Market, by Drug Type 2021 & 2028 (%)
Figure 21. Branded: MEA Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 22. Generics: MEA Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 23. MEA Malaria Treatment Market, by Route of Administration 2021 & 2028 (%)
Figure 24. Oral: MEA Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 25. Parenteral and Intravenous Mode: MEA Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 26. MEA Malaria Treatment Market, by Distribution Channel 2021 & 2028 (%)
Figure 27. Direct Tender: MEA Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 28. Hospital Pharmacies: MEA Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 29. Retail Pharmacies: MEA Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 30. Online Pharmacies: MEA Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 31. Others: MEA Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 32. MEA Malaria Treatment Market, by End User 2021 & 2028 (%)
Figure 33. Hospitals: MEA Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 34. Specialty Clinics: MEA Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 35. Homecare: MEA Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 36. Others: MEA Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 37. MEA Malaria Treatment Market Revenue Overview, by Country, 2021 (US$ Million)
Figure 38. MEA: Malaria Treatment Market, by Country, 2021 & 2028 (%)
Figure 39. UAE: Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)
Figure 40. Saudi Arabia: Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)
Figure 41. South Africa: Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)
Figure 42. Nigeria: Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)
Figure 43. The Democratic Republic of Congo: Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)
Figure 44. United Republic of Tanzania: Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)
Figure 45. Mozambique: Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)
Figure 46. Uganda: Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)
Figure 47. Ghana: Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)
Figure 48. Burkina Faso: Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)
Figure 49. Kenya: Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)
Figure 50. Zambia: Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)
Figure 51. Rest of the MEA: Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)

Product Code: BMIRE00027939

The MEA malaria treatment market is expected to grow from US$ 51.35 million in 2022 to US$ 63.02 million by 2028. It is estimated to grow at a CAGR of 3.5% from 2022 to 2028.

Increasing Prevalence of Malaria is Fueling the MEA Malaria Treatment Market

According to the World Health Organization (WHO), malaria is an acute febrile illness caused by plasmodium parasites, which spread through the bites of infected female Anopheles mosquitoes. Malaria is caused by five parasite species in humans, and two of these species-Plasmodium falciparum and P. vivax-pose the greatest threat. P. falciparum is the deadliest malarial parasite, and it is the most widespread one on the African continent. The WHO's African region continues to account for a disproportionately high share of the global burden of malaria. In 2020, 95% of the global cases of malaria and 96% of deaths were reported in Africa; ~80% of the total deaths caused by malaria are reported in children below five years of age. Four African countries-Nigeria (31.9%), the Democratic Republic of the Congo (13.2%), the United Republic of Tanzania (4.1%), and Mozambique (3.8%)-accounted for nearly half of all malaria-related deaths reported worldwide. According to the LANCET Regional Health 2020, the burden of malaria is the highest in African countries (95%); P. falciparum is the cause of the brunt of mortality in children younger than 5 (~ 77%) across the world, and in African countries, this species accounts for ~ 96% of total mortalities caused among children by malaria. The rising prevalence of malaria boosts the MEA malaria treatment market t growth.

MEA Malaria Treatment Market Overview

The MEA malaria treatment market is categorized into the UAE, Saudi Arabia, South Africa, Nigeria, The Democratic Republic of Congo, the United Republic of Tanzania, Mozambique, Uganda, Ghana, Burkino Faso, Kenya, Zambia, and the Rest of MEA. In 2021, Saudi Arabia was the largest market for malaria treatment in the region. In 2020, Saudi Arabia witnessed 3,367 people infected with malaria. Additionally, 3,304 cases of malaria (98%) were recorded among teenagers aged 15 and above. The current elimination or treatment strategies in Saudi Arabia focus mainly on targeting the high-risk areas for sustained preventative measures, including management of infection through rapid confirmed diagnosis and treatment. Individual case follow-up and reactive surveillance with appropriate treatment and vector control and active case detection at borders with screening and treatment. Current malaria treatments are also based on the use of artemisinin-based combinations. In Saudi Arabia, the combination of pyrimethamine/sulfadoxine/artesunate is the first line of treatment for uncomplicated malaria, while lumefantrine/artemether (Coartem) is used as a second option. The treatment for severe malaria rests on the use of quinine or artesunate.

MEA Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)

MEA Malaria Treatment Market Segmentation

The MEA malaria treatment market is segmented based on treatment, drug type, route of administration, distribution channel, end user, and country.

Based on treatment, the MEA malaria treatment market is segmented into prescription medications, vaccines, diagnostic tests, and others. The diagnostic tests segment held the largest market share in 2022. The prescription medications segment is further categorized into chloroquine phosphate, artemisinin-based combination therapies (ACTs), atovaquone-proguanil, quinine sulfate (qualaquin) with doxycycline, primaquine phosphate, and others.

Based on drug type, the MEA malaria treatment market is bifurcated into branded and generic. The generic segment held a larger market share in 2022.

Based on route of administration, the MEA malaria treatment market is bifurcated into oral and parenteral & intravenous. The oral segment held a larger market share in 2022.

Based on distribution channel, the MEA malaria treatment market is segmented into direct tender, hospital pharmacies, retail pharmacies, online pharmacies, and others. The direct tender segment held the largest market share in 2022.

Based on end user, the MEA malaria treatment market is segmented into hospitals, specialty clinics, homecare, and others. The specialty clinics segment held the largest market share in 2022.

Based on country, the MEA malaria treatment market has been categorized into Saudi Arabia, South Africa, the UAE, Nigeria, The Democratic Republic of Congo, the United Republic of Tanzania, Mozambique, Uganda, Ghana, Burkina Faso, Kenya, Zambia, and the Rest of MEA. Our regional analysis states that Saudi Arabia dominated the market in 2022.

AdvaCare Pharma USA LLC, Cipla Ltd, GSK Plc, Lupin Ltd, Novartis AG, Sanofi SA, Sun Pharmaceutical Industries Ltd, Viatris Inc, and Zydus Healthcare Ltd are among the leading companies operating in the MEA malaria treatment market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the MEA malaria treatment market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the MEA malaria treatment market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth MEA market trends and outlook coupled with the factors driving the malaria treatment market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 MEA Malaria Treatment Market - By Treatment
- 1.3.2 MEA Malaria Treatment Market - By Drug Type
- 1.3.3 MEA Malaria Treatment Market - By Route of Administration
- 1.3.4 MEA Malaria Treatment Market - By Distribution Channel
- 1.3.5 MEA Malaria Treatment Market - By End User
- 1.3.6 MEA Malaria Treatment Market- By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. MEA Malaria Treatment Market- Market Landscape

4.1 Overview
4.2 MEA PEST Analysis
4.3 Experts Opinion

5. MEA Malaria Treatment Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Increasing Prevalence of Malaria
- 5.1.2 Government and Private Sector's Initiatives to Raise Awareness About Malaria
5.2 Market Restraints
- 5.2.1 Counterfeit Antimalarial Drugs and Subsequent Drug Resistance
5.3 Market Opportunities
- 5.3.1 Extending Pipeline of New Drugs and Vaccines
5.4 Future Trends
- 5.4.1 Rapid Diagnostic Tests
5.5 Impact Analysis

6. Malaria Treatment Market- MEA Analysis

6.1 MEA Malaria Treatment Market Revenue Forecast and Analysis

7. MEA Malaria Treatment Market Analysis - By Treatment

7.1 Overview
7.2 MEA Malaria Treatment Market, By Treatment 2021 & 2028 (%)
7.3 Prescription Medications
- 7.3.1 Overview
- 7.3.2 Prescription Medication Market Revenue and Forecast to 2028 (US$ Mn)
- 7.3.3 Chloroquine Phosphate
  - 7.3.3.1 Overview
  - 7.3.3.2 Chloroquine Phosphate Market Revenue and Forecast to 2028 (US$ Mn)
- 7.3.4 Artemisinin- based Combination Therapies (ACTs)
  - 7.3.4.1 Overview
  - 7.3.4.2 Artemisinin- based Combination Therapies (ACTs) Market Revenue and Forecast to 2028 (US$ Mn)
- 7.3.5 Atovaquone-Proguanil
  - 7.3.5.1 Overview
  - 7.3.5.2 Atovaquone-Proguanil Market Revenue and Forecast to 2028 (US$ Mn)
- 7.3.6 Quinine Sulphate (Qualaquin) with Doxycycline
  - 7.3.6.1 Overview
  - 7.3.6.2 Quinine Sulphate (Qualaquin) with Doxycycline Market Revenue and Forecast to 2028 (US$ Mn)
- 7.3.7 Primaquine Phosphate
  - 7.3.7.1 Overview
  - 7.3.7.2 Primaquine Phosphate Market Revenue and Forecast to 2028 (US$ Mn)
- 7.3.8 Others
  - 7.3.8.1 Overview
  - 7.3.8.2 Others Market Revenue and Forecast to 2028 (US$ Mn)
7.4 Vaccines
- 7.4.1 Overview
- 7.4.2 Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
7.5 Diagnostic Tests
- 7.5.1 Overview
- 7.5.2 Diagnostic Tests Market Revenue and Forecast to 2028 (US$ Mn)
7.6 Others
- 7.6.1 Overview
- 7.6.2 Others Market Revenue and Forecast to 2028 (US$ Mn)

8. MEA Malaria Treatment Market Analysis - By Drug Type

8.1 Overview
8.2 MEA Malaria Treatment Market, By Drug Type 2021 & 2028 (%)
8.3 Branded
- 8.3.1 Overview
- 8.3.2 Branded Market Revenue and Forecast to 2028 (US$ Mn)
8.4 Generics
- 8.4.1 Overview
- 8.4.2 Generics Market Revenue and Forecast to 2028 (US$ Mn)

9. MEA Malaria Treatment Market Analysis - By Route of Administration

9.1 Overview
9.2 MEA Malaria Treatment Market, By Route of Administration 2021 & 2028 (%)
9.3 Oral
- 9.3.1 Overview
- 9.3.2 Oral Market Revenue and Forecast to 2028 (US$ Mn)
9.4 Parenteral and Intravenous Mode
- 9.4.1 Overview
- 9.4.2 Parenteral and Intravenous Mode Market Revenue and Forecast to 2028 (US$ Mn)

10. MEA Malaria Treatment Market Analysis - By Distribution Channel

10.1 Overview
10.2 MEA Malaria Treatment Market, By Distribution Channel 2021 & 2028 (%)
10.3 Direct Tender
- 10.3.1 Overview
- 10.3.2 Direct Tender Market Revenue and Forecast to 2028 (US$ Mn)
10.4 Hospital Pharmacies
- 10.4.1 Overview
- 10.4.2 Hospital Pharmacies Market Revenue and Forecast to 2028 (US$ Mn)
10.5 Retail Pharmacies
- 10.5.1 Overview
- 10.5.2 Retail Pharmacies Market Revenue and Forecast to 2028 (US$ Mn)
10.6 Online Pharmacies
- 10.6.1 Overview
- 10.6.2 Online Pharmacies Market Revenue and Forecast to 2028 (US$ Mn)
10.7 Others
- 10.7.1 Overview
- 10.7.2 Others Market Revenue and Forecast to 2028 (US$ Mn)

11. MEA Malaria Treatment Market Analysis - By End User

11.1 Overview
11.2 MEA Malaria Treatment Market, By End User 2021 & 2028 (%)
11.3 Hospitals
- 11.3.1 Overview
- 11.3.2 Hospitals Market Revenue and Forecast to 2028 (US$ Mn)
11.4 Specialty Clinics
- 11.4.1 Overview
- 11.4.2 Specialty Clinics Market Revenue and Forecast to 2028 (US$ Mn)
11.5 Homecare
- 11.5.1 Overview
- 11.5.2 Homecare Market Revenue and Forecast to 2028 (US$ Mn)
11.6 Others
- 11.6.1 Overview
- 11.6.2 Others Market Revenue and Forecast to 2028 (US$ Mn)

12. MEA Malaria Treatment Market - Country Analysis

12.1 Overview
- 12.1.2 MEA: Malaria Treatment Market, by Country, 2021 & 2028 (%)
  - 12.1.2.1 UAE: Malaria Treatment Market - Revenue and Forecast to 2028 (USD Million)
    - 12.1.2.1.1 Overview
    - 12.1.2.1.2 UAE: Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)
    - 12.1.2.1.3 UAE: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)
    - 12.1.2.1.3.1 UAE: Malaria Treatment Market, by Prescription Medication, 2020-2028 (US$ Million)
    - 12.1.2.1.4 UAE: Malaria Treatment Market Revenue and Forecasts To 2028, By Drug Type (US$ Million)
    - 12.1.2.1.5 UAE: Malaria Treatment Market Revenue and Forecasts To 2028, By Route of Administration (US$ Million)
    - 12.1.2.1.6 UAE: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
    - 12.1.2.1.7 UAE: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  - 12.1.2.2 Saudi Arabia: Malaria Treatment Market - Revenue and Forecast to 2028 (USD Million)
    - 12.1.2.2.1 Overview
    - 12.1.2.2.2 Saudi Arabia Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)
    - 12.1.2.2.3 Saudi Arabia: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)
    - 12.1.2.2.3.1 Saudi Arabia: Malaria Treatment Market, by Prescription Medication, 2020-2028 (US$ Million)
    - 12.1.2.2.4 Saudi Arabia: Malaria Treatment Market Revenue and Forecasts To 2028, By Drug Type (US$ Million)
    - 12.1.2.2.5 Saudi Arabia: Malaria Treatment Market Revenue and Forecasts To 2028, By Route of Administration (US$ Million)
    - 12.1.2.2.6 Saudi Arabia: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
    - 12.1.2.2.7 Saudi Arabia: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  - 12.1.2.3 South Africa: Malaria Treatment Market - Revenue and Forecast to 2028 (USD Million)
    - 12.1.2.3.1 Overview
    - 12.1.2.3.2 South Africa Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)
    - 12.1.2.3.3 South Africa: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)
    - 12.1.2.3.3.1 South Africa: Malaria Treatment Market, by Prescription Medication, 2020-2028 (US$ Million)
    - 12.1.2.3.4 South Africa: Metabolomics Market Revenue and Forecasts To 2028, By Drug Type (US$ Million)
    - 12.1.2.3.5 South Africa: Metabolomics Market Revenue and Forecasts To 2028, By Route of Administration (US$ Million)
    - 12.1.2.3.6 South Africa: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
    - 12.1.2.3.7 South Africa: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  - 12.1.2.4 Nigeria: Malaria Treatment Market - Revenue and Forecast to 2028 (USD Million)
    - 12.1.2.4.1 Overview
    - 12.1.2.4.2 Nigeria: Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)
    - 12.1.2.4.3 Nigeria: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)
    - 12.1.2.4.3.1 Nigeria: Malaria Treatment Market, by Prescription Medication, 2020-2028 (US$ Million)
    - 12.1.2.4.4 Nigeria: Malaria Treatment Market Revenue and Forecasts To 2028, By Drug Type (US$ Million)
    - 12.1.2.4.5 Nigeria: Malaria Treatment Market Revenue and Forecasts To 2028, By Route of Administration (US$ Million)
    - 12.1.2.4.6 Nigeria: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
    - 12.1.2.4.7 Nigeria: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  - 12.1.2.5 The Democratic Republic of Congo: Malaria Treatment Market - Revenue and Forecast to 2028 (USD Million)
    - 12.1.2.5.1 Overview
    - 12.1.2.5.2 The Democratic Republic of Congo: Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)
    - 12.1.2.5.3 The Democratic Republic of Congo: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)
    - 12.1.2.5.3.1 The Democratic Republic of Congo: Malaria Treatment Market, by Prescription Medication, 2020-2028 (US$ Million)
    - 12.1.2.5.4 The Democratic Republic of Congo: Malaria Treatment Market Revenue and Forecasts To 2028, By Drug Type (US$ Million)
    - 12.1.2.5.5 The Democratic Republic of Congo: Malaria Treatment Market Revenue and Forecasts To 2028, By Route of Administration (US$ Million)
    - 12.1.2.5.6 The Democratic Republic of Congo: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
    - 12.1.2.5.7 The Democratic Republic of Congo: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  - 12.1.2.6 United Republic of Tanzania: Malaria Treatment Market - Revenue and Forecast to 2028 (USD Million)
    - 12.1.2.6.1 Overview
    - 12.1.2.6.2 United Republic of Tanzania Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)
    - 12.1.2.6.3 United Republic of Tanzania: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)
    - 12.1.2.6.3.1 United Republic of Tanzania: Malaria Treatment Market, by Prescription Medication, 2020-2028 (US$ Million)
    - 12.1.2.6.4 United Republic of Tanzania: Malaria Treatment Market Revenue and Forecasts To 2028, By Drug Type (US$ Million)
    - 12.1.2.6.5 United Republic of Tanzania: Malaria Treatment Market Revenue and Forecasts To 2028, By Route of Administration (US$ Million)
    - 12.1.2.6.6 United Republic of Tanzania: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
    - 12.1.2.6.7 United Republic of Tanzania: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  - 12.1.2.7 Mozambique: Malaria Treatment Market - Revenue and Forecast to 2028 (USD Million)
    - 12.1.2.7.1 Overview
    - 12.1.2.7.2 Mozambique: Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)
    - 12.1.2.7.3 Mozambique: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)
    - 12.1.2.7.3.1 Mozambique: Malaria Treatment Market, by Prescription Medication, 2020-2028 (US$ Million)
    - 12.1.2.7.4 Mozambique: Metabolomics Market Revenue and Forecasts To 2028, By Drug Type (US$ Million)
    - 12.1.2.7.5 Mozambique: Metabolomics Market Revenue and Forecasts To 2028, By Route of Administration (US$ Million)
    - 12.1.2.7.6 Mozambique: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
    - 12.1.2.7.7 Mozambique: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  - 12.1.2.8 Uganda: Malaria Treatment Market - Revenue and Forecast to 2028 (USD Million)
    - 12.1.2.8.1 Overview
    - 12.1.2.8.2 Uganda Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)
    - 12.1.2.8.3 Uganda: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)
    - 12.1.2.8.3.1 Uganda: Malaria Treatment Market, by Prescription Medication, 2020-2028 (US$ Million)
    - 12.1.2.8.4 Uganda: Malaria Treatment Market Revenue and Forecasts To 2028, By Drug Type (US$ Million)
    - 12.1.2.8.5 Uganda: Malaria Treatment Market Revenue and Forecasts To 2028, By Route of Administration (US$ Million)
    - 12.1.2.8.6 Uganda: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
    - 12.1.2.8.7 Uganda: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  - 12.1.2.9 Ghana: Malaria Treatment Market - Revenue and Forecast to 2028 (USD Million)
    - 12.1.2.9.1 Overview
    - 12.1.2.9.2 Ghana Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)
    - 12.1.2.9.3 Ghana: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)
    - 12.1.2.9.3.1 Ghana: Malaria Treatment Market, by Prescription Medication, 2020-2028 (US$ Million)
    - 12.1.2.9.4 Ghana: Metabolomics Market Revenue and Forecasts To 2028, By Drug Type (US$ Million)
    - 12.1.2.9.5 Ghana: Metabolomics Market Revenue and Forecasts To 2028, By Route of Administration (US$ Million)
    - 12.1.2.9.6 Ghana: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
    - 12.1.2.9.7 Ghana: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  - 12.1.2.10 Burkina Faso: Malaria Treatment Market - Revenue and Forecast to 2028 (USD Million)
    - 12.1.2.10.1 Overview
    - 12.1.2.10.2 Burkina Faso Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)
    - 12.1.2.10.3 Burkina Faso: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)
    - 12.1.2.10.3.1 Burkina Faso: Malaria Treatment Market, by Prescription Medication, 2020-2028 (US$ Million)
    - 12.1.2.10.4 Burkina Faso: Malaria Treatment Market Revenue and Forecasts To 2028, By Drug Type (US$ Million)
    - 12.1.2.10.5 Burkina Faso: Malaria Treatment Market Revenue and Forecasts To 2028, By Route of Administration (US$ Million)
    - 12.1.2.10.6 Burkina Faso: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
    - 12.1.2.10.7 Burkina Faso: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  - 12.1.2.11 Kenya: Malaria Treatment Market - Revenue and Forecast to 2028 (USD Million)
    - 12.1.2.11.1 Overview
    - 12.1.2.11.2 Kenya Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)
    - 12.1.2.11.3 Kenya: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)
    - 12.1.2.11.3.1 Kenya: Malaria Treatment Market, by Prescription Medication, 2020-2028 (US$ Million)
    - 12.1.2.11.4 Kenya: Malaria Treatment Market Revenue and Forecasts To 2028, By Drug Type (US$ Million)
    - 12.1.2.11.5 Kenya: Malaria Treatment Market Revenue and Forecasts To 2028, By Route of Administration (US$ Million)
    - 12.1.2.11.6 Kenya: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
    - 12.1.2.11.7 Kenya: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  - 12.1.2.12 Zambia: Malaria Treatment Market - Revenue and Forecast to 2028 (USD Million)
    - 12.1.2.12.1 Overview
    - 12.1.2.12.2 Zambia Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)
    - 12.1.2.12.3 Zambia: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)
    - 12.1.2.12.3.1 Zambia: Malaria Treatment Market, by Prescription Medication, 2020-2028 (US$ Million)
    - 12.1.2.12.4 Zambia: Metabolomics Market Revenue and Forecasts To 2028, By Drug Type (US$ Million)
    - 12.1.2.12.5 Zambia: Metabolomics Market Revenue and Forecasts To 2028, By Route of Administration (US$ Million)
    - 12.1.2.12.6 Zambia: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
    - 12.1.2.12.7 Zambia: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  - 12.1.2.13 Rest of the MEA: Malaria Treatment Market - Revenue and Forecast to 2028 (USD Million)
    - 12.1.2.13.1 Overview
    - 12.1.2.13.2 Rest of the MEA Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)
    - 12.1.2.13.3 Rest of MEA: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)
    - 12.1.2.13.3.1 Rest of MEA: Malaria Treatment Market, by Prescription Medication, 2020-2028 (US$ Million)
    - 12.1.2.13.4 Rest of MEA: Metabolomics Market Revenue and Forecasts To 2028, By Drug Type (US$ Million)
    - 12.1.2.13.5 Rest of MEA: Metabolomics Market Revenue and Forecasts To 2028, By Route of Administration (US$ Million)
    - 12.1.2.13.6 Rest of MEA: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
    - 12.1.2.13.7 Rest of MEA: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)

13. Industry Landscape

13.1 Overview
13.2 Inorganic Growth Strategies
- 13.2.1 Overview
13.3 Organic Growth Strategies
- 13.3.1 Overview

14. Company Profiles

14.1 Zydus Healthcare Ltd
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Sun Pharmaceutical Industries Ltd
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 Sanofi SA
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 GSK Plc
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Novartis AG
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 Cipla Ltd
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 Viatris Inc
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 Lupin Ltd
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 AdvaCare Pharma USA LLC
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments

15. Appendix

15.1 About The Insight Partners

中東・アフリカのマラリア治療薬市場の2028年までの予測-地域別分析-治療薬、薬剤タイプ、投与経路、流通チャネル、エンドユーザー別

Middle East & Africa Malaria Treatment Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Treatment, Drug Type, Route of Administration, Distribution Channel, and End User

目次

第1章イントロダクション

第2章重要なポイント

第3章調査手法

第4章中東・アフリカのマラリア治療市場- 市場情勢

第5章中東・アフリカのマラリア治療市場-主要市場力学

第6章マラリア治療市場-中東・アフリカの分析

第7章中東・アフリカのマラリア治療市場分析：治療別

第8章中東・アフリカのマラリア治療市場の分析：薬剤タイプ別

第9章中東・アフリカのマラリア治療市場の分析：投与経路別

第10章中東・アフリカのマラリア治療市場の分析：流通チャネル別

第11章中東・アフリカのマラリア治療薬の市場分析：エンドユーザー別

第12章中東・アフリカのマラリア治療市場：国別分析

第13章業界情勢

第14章企業プロファイル

第15章付録

List Of Tables

List Of Figures

Reasons to Buy:

Table Of Contents

1. Introduction

2. Key Takeaways

3. Research Methodology

4. MEA Malaria Treatment Market- Market Landscape

5. MEA Malaria Treatment Market - Key Market Dynamics

6. Malaria Treatment Market- MEA Analysis

7. MEA Malaria Treatment Market Analysis - By Treatment

8. MEA Malaria Treatment Market Analysis - By Drug Type

9. MEA Malaria Treatment Market Analysis - By Route of Administration

10. MEA Malaria Treatment Market Analysis - By Distribution Channel

11. MEA Malaria Treatment Market Analysis - By End User

12. MEA Malaria Treatment Market - Country Analysis

13. Industry Landscape

14. Company Profiles

15. Appendix

中東・アフリカのマラリア治療薬市場の2028年までの予測-地域別分析-治療薬、薬剤タイプ、投与経路、流通チャネル、エンドユーザー別

Middle East & Africa Malaria Treatment Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Treatment, Drug Type, Route of Administration, Distribution Channel, and End User

目次

第1章 イントロダクション

第2章 重要なポイント

第3章 調査手法

第4章 中東・アフリカのマラリア治療市場- 市場情勢

第5章 中東・アフリカのマラリア治療市場-主要市場力学

第6章 マラリア治療市場-中東・アフリカの分析

第7章 中東・アフリカのマラリア治療市場分析：治療別

第8章 中東・アフリカのマラリア治療市場の分析：薬剤タイプ別

第9章 中東・アフリカのマラリア治療市場の分析：投与経路別

第10章 中東・アフリカのマラリア治療市場の分析：流通チャネル別

第11章 中東・アフリカのマラリア治療薬の市場分析：エンドユーザー別

第12章 中東・アフリカのマラリア治療市場：国別分析

第13章 業界情勢

第14章 企業プロファイル

第15章 付録

List Of Tables

List Of Figures

Reasons to Buy:

Table Of Contents

1. Introduction

2. Key Takeaways

3. Research Methodology

4. MEA Malaria Treatment Market- Market Landscape

5. MEA Malaria Treatment Market - Key Market Dynamics

6. Malaria Treatment Market- MEA Analysis

7. MEA Malaria Treatment Market Analysis - By Treatment

8. MEA Malaria Treatment Market Analysis - By Drug Type

9. MEA Malaria Treatment Market Analysis - By Route of Administration

10. MEA Malaria Treatment Market Analysis - By Distribution Channel

11. MEA Malaria Treatment Market Analysis - By End User

12. MEA Malaria Treatment Market - Country Analysis

13. Industry Landscape

14. Company Profiles

15. Appendix

第1章イントロダクション

第2章重要なポイント

第3章調査手法

第4章中東・アフリカのマラリア治療市場- 市場情勢

第5章中東・アフリカのマラリア治療市場-主要市場力学

第6章マラリア治療市場-中東・アフリカの分析

第7章中東・アフリカのマラリア治療市場分析：治療別

第8章中東・アフリカのマラリア治療市場の分析：薬剤タイプ別

第9章中東・アフリカのマラリア治療市場の分析：投与経路別

第10章中東・アフリカのマラリア治療市場の分析：流通チャネル別

第11章中東・アフリカのマラリア治療薬の市場分析：エンドユーザー別

第12章中東・アフリカのマラリア治療市場：国別分析

第13章業界情勢

第14章企業プロファイル

第15章付録